LivaNova PLC (LIVN) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
Revenue: $319 million, an increase of 10% versus 2023. Cardiopulmonary Segment Revenue: $174 million, an increase of 14% versus Q2 2023. Heart-Lung Machine Revenue: Increased over 25% driven by Essenz...